Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) currently has a daily average trading volume of 3.97M but it saw 2982920 shares traded in last market. With a market cap of 142.18M USD, the company’s current market price of $0.88 came rising about 13.45 while comparing to the previous closing price of $0.77. In past 52 weeks, the stock remained buoying in the range of price level as high as $8.45 and as low as $0.59. In the recent trading on the day, stock has struck highest price mark of $0.7501 while lowest mark touched by it was $0.89.
Taking a look at 20-day trading activity of Ironwood Pharmaceuticals Inc (IRWD) gives us an average price of $1.0590, while its current price level is -89.60% below from 52-week high level whereas it is 48.68% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.4020 while that of 200 days or SMA-200 reads an average of $3.6578. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.39% during that period while stretching the period over a month that decreases to 13.02%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 36.06 which implies that the stock is in neutral territory.
Over the week, IRWD’s stock price is moving 17.16% up while it is -41.42% when we observe its performance for the past one month. Year-to-date it is -80.16% down and over the past year, the stock is showing a downside performance of -89.10%.
The company is expected to be releasing its next quarterly report on 2025-Feb-26, for which analysts forecasted an EPS of -0.01 while estimate for next year EPS is 0.16. In next quarter, company is expected to be making quarterly sales of $72.03M as analysts are expecting the sales for current fiscal year at $287.07M and seeing the company making $308.36M in sales next year. Moreover, analysts are in estimates of $66.77M for current-quarter revenue.
Currently, Ironwood Pharmaceuticals Inc’s total number of outstanding shares is 160.21M with 1.94% of that held by the insiders while 102.23% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 0.61% and return on equity (ROE) at -559.14%. It has a price to earnings ratio (P/E ratio) of 81.36 while having a 2.59 of forward P/E ratio. Stock’s beta reads 0.49. Stock has a price to sale or P/S ratio amounts to 0.40. Its return on asset (ROA) is 0.44% on average.
